ATE327257T1 - Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung - Google Patents
Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellungInfo
- Publication number
- ATE327257T1 ATE327257T1 AT00480090T AT00480090T ATE327257T1 AT E327257 T1 ATE327257 T1 AT E327257T1 AT 00480090 T AT00480090 T AT 00480090T AT 00480090 T AT00480090 T AT 00480090T AT E327257 T1 ATE327257 T1 AT E327257T1
- Authority
- AT
- Austria
- Prior art keywords
- orthocilical
- concentrated
- stable
- solid
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9913062A FR2799758B1 (fr) | 1999-10-15 | 1999-10-15 | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE327257T1 true ATE327257T1 (de) | 2006-06-15 |
Family
ID=9551123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00480090T ATE327257T1 (de) | 1999-10-15 | 2000-10-05 | Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung |
Country Status (13)
Country | Link |
---|---|
US (1) | US6335457B1 (de) |
EP (1) | EP1092728B1 (de) |
JP (1) | JP4729161B2 (de) |
CN (1) | CN1202130C (de) |
AR (1) | AR026030A1 (de) |
AT (1) | ATE327257T1 (de) |
AU (1) | AU774668B2 (de) |
BR (2) | BRPI0004827B8 (de) |
DE (1) | DE60028152T2 (de) |
ES (1) | ES2262496T3 (de) |
FR (1) | FR2799758B1 (de) |
MX (1) | MXPA00010013A (de) |
PT (1) | PT1092728E (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1371289A1 (de) * | 2002-03-20 | 2003-12-17 | Bio Minerals N.V. | Cholin-Kieselsäure-Komplex |
US9078465B2 (en) | 2002-03-20 | 2015-07-14 | Bio Minerals N.V. | Choline-silicic acid complex with osmolytes and divalent trace elements |
EP1391426A1 (de) * | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Verfahren zur Herstellung eines kieselsäureenthaltenden Extrudates, das Extrudat, dessen Verwendung und eine das Extrudat enthaltende pharmazeutische Zusammensetzung |
US7887851B2 (en) * | 2004-06-07 | 2011-02-15 | Kao Corporation | Aromatase activator |
FR2911495B1 (fr) * | 2007-01-23 | 2014-06-27 | Oreal | Utilisation cosmetique d'associations de fer pour le soin de la peau. |
EP3305305B1 (de) | 2007-10-15 | 2021-06-09 | HS Pharmaceuticals, LLC | Silikathaltige zusammensetzungen und verfahren zur behandlung |
GB0720423D0 (en) * | 2007-10-19 | 2007-11-28 | Univ Leuven Kath | Method for brewing beer |
WO2009127256A1 (en) * | 2008-04-17 | 2009-10-22 | Jisbrey, S.A | Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use |
WO2011010188A1 (en) * | 2009-07-23 | 2011-01-27 | Societe Anonyme Des Eaux Minerales D'evian "S.A.E.M.E" | A process for producing water enriched with natural orthosilicic acid |
GB0913255D0 (en) | 2009-07-30 | 2009-09-02 | Sisaf Ltd | Topical composition |
DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
DE102010008981A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
ES2525450T3 (es) | 2011-05-26 | 2014-12-23 | Dexsil Labs | Preparación biológica líquida que contiene un complejo de silicio biodisponible, su procedimiento de producción y su utilización |
CN103113847B (zh) * | 2013-01-31 | 2015-04-01 | 重庆知德文化传播有限公司 | 竹制品或木制品粘合剂的制备工艺 |
GB201402672D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
FR3049190B1 (fr) * | 2016-03-22 | 2019-07-26 | Societe Des Eaux De Source De Treignac | Eau concentree enrichie en acide orthosilicique naturel |
US10253090B2 (en) | 2016-03-22 | 2019-04-09 | Avicenna Nutraceutical, Llc | Hydrolyzed collagen compositions and methods of making thereof |
GB201904336D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
LU101518B1 (fr) | 2019-12-03 | 2021-06-07 | Intellectual Property Monitor | Complexe à base d'acide ortho-silicique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA972288A (en) * | 1971-01-20 | 1975-08-05 | Gyorgy Hajos | Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity |
NL9400189A (nl) * | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
JP3643994B2 (ja) * | 1995-12-18 | 2005-04-27 | コニカミノルタホールディングス株式会社 | インクジェット用記録媒体 |
FR2761075B1 (fr) | 1997-03-24 | 1999-06-11 | Seguin Marie Christine | Nouveaux composes a base de silicium biologiquement actifs et leurs applications therapeutiques |
-
1999
- 1999-10-15 FR FR9913062A patent/FR2799758B1/fr not_active Expired - Lifetime
-
2000
- 2000-10-05 ES ES00480090T patent/ES2262496T3/es not_active Expired - Lifetime
- 2000-10-05 DE DE60028152T patent/DE60028152T2/de not_active Expired - Lifetime
- 2000-10-05 EP EP00480090A patent/EP1092728B1/de not_active Expired - Lifetime
- 2000-10-05 AU AU62492/00A patent/AU774668B2/en not_active Ceased
- 2000-10-05 PT PT00480090T patent/PT1092728E/pt unknown
- 2000-10-05 AT AT00480090T patent/ATE327257T1/de active
- 2000-10-12 JP JP2000311945A patent/JP4729161B2/ja not_active Expired - Fee Related
- 2000-10-12 US US09/686,882 patent/US6335457B1/en not_active Expired - Lifetime
- 2000-10-13 AR ARP000105387A patent/AR026030A1/es not_active Application Discontinuation
- 2000-10-13 BR BRPI0004827A patent/BRPI0004827B8/pt not_active IP Right Cessation
- 2000-10-13 CN CNB001344129A patent/CN1202130C/zh not_active Expired - Fee Related
- 2000-10-13 BR BRPI0004827-5B1A patent/BR0004827B1/pt not_active IP Right Cessation
- 2000-10-13 MX MXPA00010013A patent/MXPA00010013A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US6335457B1 (en) | 2002-01-01 |
AU774668B2 (en) | 2004-07-01 |
CN1298881A (zh) | 2001-06-13 |
BR0004827A (pt) | 2001-05-22 |
EP1092728A2 (de) | 2001-04-18 |
FR2799758B1 (fr) | 2002-05-17 |
JP2001158798A (ja) | 2001-06-12 |
EP1092728A3 (de) | 2001-12-05 |
AR026030A1 (es) | 2002-12-26 |
FR2799758A1 (fr) | 2001-04-20 |
EP1092728B1 (de) | 2006-05-24 |
DE60028152T2 (de) | 2007-03-15 |
AU6249200A (en) | 2001-04-26 |
BRPI0004827B8 (pt) | 2022-06-28 |
MXPA00010013A (es) | 2005-02-17 |
PT1092728E (pt) | 2006-09-29 |
BR0004827B1 (pt) | 2014-09-30 |
CN1202130C (zh) | 2005-05-18 |
ES2262496T3 (es) | 2006-12-01 |
DE60028152D1 (de) | 2006-06-29 |
JP4729161B2 (ja) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE327257T1 (de) | Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung | |
DE60006298D1 (de) | Verfahren zur Herstellung von Kohlendioxid | |
DE60017336D1 (de) | Zusammensetzung zur Herstellung von Harzen | |
ATE304442T1 (de) | Anlage zur gleichzeitigen herstellung von verschiedenartigen reifen | |
DE60002526D1 (de) | Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole | |
ZA200208135B (en) | Materials and method for the biological production of sulfuric acid. | |
ATE344276T1 (de) | Polyamidnukleinsäure-derivate, mittel und verfahren zur ihrer herstellung | |
DE60115358D1 (de) | Geformter Katalysator zur Herstellung von Triethylendiamin, Verfahren zu dessen Herstellung, und Verfahren zur Herstellung von Triethylendiamin | |
IL147527A0 (en) | Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes | |
DE60015512D1 (de) | Wässrige dispersionszusammensetzung und verfahren zur herstellung davon | |
ZA200202834B (en) | Plants having altered amino acid contents and method for the production thereof. | |
DE50001758D1 (de) | Verfahren und Anlage zur Herstellung von 1,2-Dichlorethan | |
DE60034843D1 (de) | Verfahren zur Herstellung von L-arginin | |
DE69916332D1 (de) | Verfahren zur herstellung von etheraminalkoxylaten | |
DE60036758D1 (de) | Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze | |
DE29906703U1 (de) | Mischer zur Herstellung von Suspensionen | |
DE60029441D1 (de) | Fadenbündel und verfahren zur dessen herstellung | |
DE60002254D1 (de) | Verfahren zur Herstellung von 4,6-diaminoresorcin | |
DE60043610D1 (de) | Verfahren zur herstellung von l-lysin | |
DE50000074D1 (de) | Verfahren zur Herstellung von halogenierten 1,2-Disilaethanen | |
DE60004931D1 (de) | Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron) | |
DE60104789D1 (de) | Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden | |
DE50005182D1 (de) | Verfahren zur adiabatischen Herstellung von 3,4-Dichlornitrobenzol | |
DE60034765D1 (de) | Verfahren zur herstellung von poly(p-dioxanon), und poly(p-dioxanon)-monofilament und verfahren zur herstellung desselben | |
DE69903610D1 (de) | Verfahren zur Herstellung von 5,5'-bi-1H-Tetrazol-Salz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1092728 Country of ref document: EP |